Detalhe da pesquisa
1.
Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
J Natl Compr Canc Netw
; 22(3)2024 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503041
2.
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial.
Lancet Oncol
; 24(10): 1073-1082, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666264
3.
Survival of Locally Advanced MSI-high Gastric Cancer Patients Treated With Perioperative Chemotherapy: A Retrospective Cohort Study.
Ann Surg
; 277(5): 798-805, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766391
4.
Waiting to Operate: The Risk of Salvage Esophagectomy.
Ann Surg
; 277(5): 781-788, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727949
5.
Induction FOLFOX and PET-Directed Chemoradiation for Locally Advanced Esophageal Adenocarcinoma.
Ann Surg
; 277(3): e538-e544, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387205
6.
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.
Ann Surg
; 278(3): e511-e518, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36762546
7.
Advances in the treatment of gastric cancer: 2022-2023.
Curr Opin Gastroenterol
; 39(6): 517-521, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678195
8.
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(4): 393-422, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015332
9.
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
Lancet Oncol
; 23(2): 259-269, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038433
10.
Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Cancer
; 128(15): 2958-2966, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35647938
11.
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(2): 167-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130500
12.
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS).
Gastric Cancer
; 25(3): 586-597, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34997449
13.
Outcomes of Neoadjuvant Chemotherapy for Clinical Stages 2 and 3 Gastric Cancer Patients: Analysis of Timing and Site of Recurrence.
Ann Surg Oncol
; 28(9): 4829-4838, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33566242
14.
Association of Obesity with Worse Operative and Oncologic Outcomes for Patients Undergoing Gastric Cancer Resection.
Ann Surg Oncol
; 28(12): 7040-7050, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33830355
15.
Advances in the treatment of gastric cancer: 2020-2021.
Curr Opin Gastroenterol
; 37(6): 615-618, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34456227
16.
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
Gastric Cancer
; 24(4): 970-977, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713215
17.
Immunotherapy in esophagogastric cancer.
Clin Adv Hematol Oncol
; 19(10): 639-647, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34637430
18.
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.
Lancet Oncol
; 21(6): 821-831, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437664
19.
Regorafenib in Combination with First-Line Chemotherapy for Metastatic Esophagogastric Cancer.
Oncologist
; 25(1): e68-e74, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570517
20.
Advances in the treatment of gastric cancer.
Curr Opin Gastroenterol
; 36(6): 525-529, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32889823